These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 24240244)

  • 1. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial.
    Nelson A; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Gemzell-Danielsson K
    Obstet Gynecol; 2013 Dec; 122(6):1205-13. PubMed ID: 24240244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system.
    Eisenberg DL; Schreiber CA; Turok DK; Teal SB; Westhoff CL; Creinin MD;
    Contraception; 2015 Jul; 92(1):10-6. PubMed ID: 25934164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Age, Parity and Body Mass Index on the Efficacy, Safety, Placement and User Satisfaction Associated With Two Low-Dose Levonorgestrel Intrauterine Contraceptive Systems: Subgroup Analyses of Data From a Phase III Trial.
    Gemzell-Danielsson K; Apter D; Hauck B; Schmelter T; Rybowski S; Rosen K; Nelson A
    PLoS One; 2015; 10(9):e0135309. PubMed ID: 26378938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase III, single-arm study of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5mg) in postmenarcheal adolescents.
    Gemzell-Danielsson K; Buhling KJ; Dermout SM; Lukkari-Lax E; Montegriffo E; Apter D
    Contraception; 2016 Jun; 93(6):507-12. PubMed ID: 26872720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Wildemeersch D; Goldstuck ND; Jackers G
    Gynecol Endocrinol; 2017 Mar; 33(3):223-226. PubMed ID: 28084114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-arm phase III study exploring the efficacy and safety of LNG-IUS 8, a low-dose levonorgestrel intrauterine contraceptive system (total content 13.5 mg), in an Asia-Pacific population.
    Fan G; Kang S; Ren M; Weisberg E; Lukkari-Lax E; Roth K; Shin S
    Contraception; 2017 Apr; 95(4):371-377. PubMed ID: 27913229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena.
    Gemzell-Danielsson K; Schellschmidt I; Apter D
    Fertil Steril; 2012 Mar; 97(3):616-22.e1-3. PubMed ID: 22222193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new, low-dose levonorgestrel intrauterine contraceptive system over 5 years of use.
    Gemzell-Danielsson K; Apter D; Dermout S; Faustmann T; Rosen K; Schmelter T; Merz M; Nelson A
    Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():22-28. PubMed ID: 27930941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ease of insertion, contraceptive efficacy and safety of new T-shaped levonorgestrel-releasing intrauterine systems.
    Wildemeersch D; Janssens D; Vrijens M; Weyers S
    Contraception; 2005 Jun; 71(6):465-9. PubMed ID: 15914138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
    Jensen JT; Lukkari-Lax E; Schulze A; Wahdan Y; Serrani M; Kroll R
    Am J Obstet Gynecol; 2022 Dec; 227(6):873.e1-873.e12. PubMed ID: 36096186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six-year contraceptive efficacy and continued safety of a levonorgestrel 52 mg intrauterine system.
    Westhoff CL; Keder LM; Gangestad A; Teal SB; Olariu AI; Creinin MD
    Contraception; 2020 Mar; 101(3):159-161. PubMed ID: 31786203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
    Pakarinen P; Luukkainen T
    Contraception; 2005 Nov; 72(5):342-5. PubMed ID: 16246659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The levonorgestrel intrauterine system in nulliparous women.
    Prager S; Darney PD
    Contraception; 2007 Jun; 75(6 Suppl):S12-5. PubMed ID: 17531602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System.
    Teal SB; Turok DK; Chen BA; Kimble T; Olariu AI; Creinin MD
    Obstet Gynecol; 2019 Jan; 133(1):63-70. PubMed ID: 30531565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of clinical experience with the frameless LNG-IUS for contraception and treatment of heavy menstrual bleeding.
    Wildemeersch D; Andrade A
    Gynecol Endocrinol; 2010 May; 26(5):383-9. PubMed ID: 20192899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
    McNicholas C; Swor E; Wan L; Peipert JF
    Am J Obstet Gynecol; 2017 Jun; 216(6):586.e1-586.e6. PubMed ID: 28147241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.
    Godfrey EM; Memmel LM; Neustadt A; Shah M; Nicosia A; Moorthie M; Gilliam M
    Contraception; 2010 Feb; 81(2):123-7. PubMed ID: 20103449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.